Trifast (TRI) H2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2026 earnings summary
3 Jul, 2026Executive summary
FY 2026 marked the first year of the 'rebuild' phase, focusing on engineering solutions, supply chain simplification, and higher-value, design-led offerings, with 60% of revenue now tied to these value propositions.
Strategic pivot toward higher growth sectors (smart infrastructure, medical equipment) and markets (North America, India, Asia), with smart infrastructure now 17% of revenue, nearly double from 2024.
Despite a 7.3% revenue decline to £207m, gross margin improved by 170bps to 30%, and underlying EBIT rose to £16.3m (7.8% margin).
Strong cash generation reduced net debt to £16m, leverage to 0.75x, and supported a dividend increase to £0.019 per share.
Transformation initiatives (Project Ignite) and operational efficiency drove margin gains and cost reductions.
Financial highlights
Revenue fell 7.3% year-over-year to £207.1m, mainly due to weaker automotive/EV demand and deliberate exit from lower-margin business.
Gross margin rose to 30% (+170bps), underlying EBIT reached £16.3m, and EBIT margin improved to 7.8% (+110bps).
Net debt reduced to £16m; leverage at 0.75x, down from 0.97x; ROCE improved to 8.5%.
Underlying diluted EPS increased by 2.15p to 6.46p.
Dividend increased to £0.019 per share, cover typically 3–4x, with a progressive policy.
Outlook and guidance
FY 2027 expected to continue momentum, with H1 similar to FY 2026 and H2 growth driven by a strong pipeline in smart infrastructure and medical equipment.
Confident in achieving double-digit EBIT margin in the medium term, driven by structural improvements rather than cyclical recovery.
Ongoing investment in digital enablement, sales capability, and geographic expansion, especially in India and North America.
Continued investment in technology (Project Ignite) and targeted bolt-on acquisitions.
Latest events from Trifast
- Margin expansion and cost savings drove profit growth, with leverage below 1.0x.TRI
H2 20253 Jul 2026 - Underlying EBIT margin rose to 7.9% as margin management offset revenue decline and sector headwinds.TRI
H2 20262 Jul 2026 - Margin gains and strategic shifts offset revenue drop, supporting medium-term EBIT targets.TRI
H2 2026 TU29 Apr 2026 - On track for FY26 expectations, focusing on margin improvement amid tough market conditions.TRI
Q3 2026 TU12 Feb 2026 - Strong financial recovery, strategic sector pivot, and all AGM resolutions approved.TRI
AGM 20253 Feb 2026 - EBIT margin improved and net debt fell sharply as focus shifts to double-digit margins and key growth sectors.TRI
H2 20242 Feb 2026 - Margins and ROCE improved despite revenue decline, with outlook and guidance maintained.TRI
H1 202620 Nov 2025 - Gross margin and ROCE improved despite revenue decline; margin targets reaffirmed.TRI
H1 202618 Nov 2025 - Margins and profits improved despite lower revenue, with net debt sharply reduced.TRI
H1 202513 Jun 2025